Travere Therapeutics shares owned by Shell Asset Management Company
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Shell Asset Management Company
from 13F filings
Historical chart of Shell Asset Management Company investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Shell Asset Management Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Shell Asset Management Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $55k | 7.1k | 7.75 |
| 2023-09-30 | $83k | 9.3k | 8.92 |
| 2023-06-30 | $145k | 9.5k | 15.34 |
| 2023-03-31 | $214k | 9.5k | 22.51 |
| 2022-12-31 | $201k | 9.5k | 21.07 |
| 2022-09-30 | $283k | 12k | 24.66 |
| 2022-06-30 | $351k | 15k | 24.23 |
| 2022-03-31 | $373k | 15k | 25.79 |
| 2021-12-31 | $515k | 17k | 31.02 |
| 2021-09-30 | $401k | 17k | 24.26 |
| 2021-06-30 | $251k | 17k | 14.56 |
| 2021-03-31 | $407k | 16k | 24.96 |
| 2020-12-31 | $188k | 6.9k | 27.32 |
More positions owned by Shell Asset Management Company
View all positions for Shell Asset Management Company